CAP and ACLA seek to delay move to single ABN form.
ACLA wants CMS to reconsider doing away with the lab-specific form, saying that much effort and expense went into creating and implementing the form, which has worked well in practice. According to the association, changing the form would require labs to re-educate patients and physicians and to incur substantial new costs to reprogram software and systems.
CAP also wants the lab-specific form retained, at least until CMS addresses the College's concerns over customizing the proposed new form, requiring disclosure of the estimated cost for the lab testing, and lab provider liability when another entity is responsible for securing the ABN from the beneficiary.
The current ABNs were scheduled to expire at the end of May under the Paperwork Reduction Act. However, until a new form is finalized, providers must continue to use the two currently approved ABNs, either of which may be used for lab services.
by AMT Legal Counsel
Michael N. McCarty
Brickfield, Burchette, Ritts & Stone, P.C.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||government news; College of American Pathologists and American Clinical Laboratory Association; Advance Beneficiary Notice|
|Author:||McCarty, Michael N.|
|Article Type:||Brief article|
|Date:||Jun 1, 2007|
|Previous Article:||Reps. English and Green reintroduce specimen collection fee legislation.|
|Next Article:||The formation of the American hospital before the twentieth century: 1st Place Winner AMT 2007 Feature Writing Contest.|